Suppr超能文献

胸膜和肺部疾病中的胸膜间皮细胞。

Pleural mesothelial cells in pleural and lung diseases.

作者信息

Batra Hitesh, Antony Veena B

机构信息

Division of Pulmonary, Allergy & Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham Birmingham, AL, USA.

出版信息

J Thorac Dis. 2015 Jun;7(6):964-80. doi: 10.3978/j.issn.2072-1439.2015.02.19.

Abstract

During development, the mesoderm maintains a complex relationship with the developing endoderm giving rise to the mature lung. Pleural mesothelial cells (PMCs) derived from the mesoderm play a key role during the development of the lung. The pleural mesothelium differentiates to give rise to the endothelium and smooth muscle cells via epithelial-to-mesenchymal transition (EMT). An aberrant recapitulation of such developmental pathways can play an important role in the pathogenesis of disease processes such as idiopathic pulmonary fibrosis (IPF). The PMC is the central component of the immune responses of the pleura. When exposed to noxious stimuli, it demonstrates innate immune responses such as Toll-like receptor (TLR) recognition of pathogen associated molecular patterns as well as causes the release of several cytokines to activate adaptive immune responses. Development of pleural effusions occurs due to an imbalance in the dynamic interaction between junctional proteins, n-cadherin and β-catenin, and phosphorylation of adherens junctions between PMCs, which is caused in part by vascular endothelial growth factor (VEGF) released by PMCs. PMCs play an important role in defense mechanisms against bacterial and mycobacterial pleural infections, and in pathogenesis of malignant pleural effusion, asbestos related pleural disease and malignant pleural mesothelioma. PMCs also play a key role in the resolution of inflammation, which can occur with or without fibrosis. Fibrosis occurs as a result of disordered fibrin turnover and due to the effects of cytokines such as transforming growth factor-β, platelet-derived growth factor (PDGF), and basic fibroblast growth factor; which are released by PMCs. Recent studies have demonstrated a role for PMCs in the pathogenesis of IPF suggesting their potential as a cellular biomarker of disease activity and as a possible therapeutic target. Pleural-based therapies targeting PMCs for treatment of IPF and other lung diseases need further exploration.

摘要

在发育过程中,中胚层与发育中的内胚层维持着复杂的关系,最终形成成熟的肺。源自中胚层的胸膜间皮细胞(PMC)在肺发育过程中起关键作用。胸膜间皮通过上皮-间充质转化(EMT)分化产生内皮细胞和平滑肌细胞。这种发育途径的异常重演在诸如特发性肺纤维化(IPF)等疾病过程的发病机制中可能起重要作用。PMC是胸膜免疫反应的核心组成部分。当暴露于有害刺激时,它会表现出天然免疫反应,如Toll样受体(TLR)对病原体相关分子模式的识别,还会导致多种细胞因子释放以激活适应性免疫反应。胸腔积液的形成是由于连接蛋白、N-钙黏蛋白和β-连环蛋白之间动态相互作用失衡,以及PMC之间黏附连接的磷酸化,部分原因是PMC释放的血管内皮生长因子(VEGF)所致。PMC在抵御细菌和分枝杆菌性胸膜感染的防御机制中以及在恶性胸腔积液、石棉相关胸膜疾病和恶性胸膜间皮瘤的发病机制中起重要作用。PMC在炎症消退过程中也起关键作用,炎症消退可伴有或不伴有纤维化。纤维化是由于纤维蛋白周转紊乱以及诸如转化生长因子-β、血小板衍生生长因子(PDGF)和碱性成纤维细胞生长因子等细胞因子的作用导致的,这些细胞因子由PMC释放。最近的研究表明PMC在IPF发病机制中起作用,提示它们作为疾病活动的细胞生物标志物以及可能的治疗靶点的潜力。针对PMC的基于胸膜的疗法用于治疗IPF和其他肺部疾病需要进一步探索。

相似文献

1
Pleural mesothelial cells in pleural and lung diseases.胸膜和肺部疾病中的胸膜间皮细胞。
J Thorac Dis. 2015 Jun;7(6):964-80. doi: 10.3978/j.issn.2072-1439.2015.02.19.
2
The pleural mesothelium in development and disease.胸膜间皮在发育和疾病中的作用。
Front Physiol. 2014 Aug 1;5:284. doi: 10.3389/fphys.2014.00284. eCollection 2014.

引用本文的文献

1
A mesothelial differentiation gateway drives fibrosis.间皮分化途径驱动纤维化。
Nat Commun. 2025 Sep 16;16(1):8295. doi: 10.1038/s41467-025-63990-2.
7
Role of ZIP kinase in development of myofibroblast differentiation from HPMCs.ZIP 激酶在 HPMCs 向肌成纤维细胞分化中的作用。
Am J Physiol Lung Cell Mol Physiol. 2024 Mar 1;326(3):L353-L366. doi: 10.1152/ajplung.00251.2023. Epub 2024 Jan 22.

本文引用的文献

3
The pleural mesothelium in development and disease.胸膜间皮在发育和疾病中的作用。
Front Physiol. 2014 Aug 1;5:284. doi: 10.3389/fphys.2014.00284. eCollection 2014.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验